Join AFA and get membership benefits

24 hours help line +44(0) 1789 451 837

Follow on Facebook
Follow AtrialFibUK on Twitter

Afib, Stroke, and the New Anticoagulants, a Roundtable

Thu, Mar 22nd 2012

The arrival of dabigatran and rivaroxaban on the U.S. market, as well as the impending FDA approval of apixaban, changes the landscape of stroke prevention in atrial fibrillation.
Read more